N-terminal proBNP - Marker of cardiac dysfunction, fluid overload, or malnutrition in hemodialysis patients?

Clinical Journal of the American Society of Nephrology

Volumn 5, Issue 6, 2010, Pages 1036-1040

  Booth, John ^a   Pinney, Jennifer ^a   Davenport, Andrew ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; CALCIUM; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; PEPTIDE FRAGMENT; PRO-BRAIN NATRIURETIC PEPTIDE (1-76);

ADULT; AGED; ARTICLE; CONCENTRATION (PARAMETERS); CORRELATION ANALYSIS; DIALYSATE; DIALYSIS; EXTRACELLULAR FLUID; EXTRACELLULAR SPACE; FEMALE; HEART DISEASE; HEMODIALYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; MEAN ARTERIAL PRESSURE; OUTPATIENT; TOTAL BODY WATER; WEIGHT CHANGE; BLOOD; BLOOD PRESSURE; BODY WATER; COMPLICATION; HEART DISEASES; IMPEDANCE; KIDNEY DISEASES; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PROGNOSIS; RENAL REPLACEMENT THERAPY; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL; UPREGULATION; WATER-ELECTROLYTE IMBALANCE;

ADULT; AGED; BIOLOGICAL MARKERS; BLOOD PRESSURE; BODY WATER; CALCIUM; ELECTRIC IMPEDANCE; FEMALE; HEART DISEASES; HUMANS; KIDNEY DISEASES; LINEAR MODELS; LOGISTIC MODELS; MALE; MALNUTRITION; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; OUTPATIENTS; PEPTIDE FRAGMENTS; PROGNOSIS; RENAL DIALYSIS; RISK ASSESSMENT; RISK FACTORS; UP-REGULATION; WATER-ELECTROLYTE IMBALANCE;

EID: 77953301294     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.09001209     Document Type: Article

References (21)

1. Foley RN, Parfrey PS: Cardiovascular disease and mortality in ESRD. J Nephrol 11: 239-245, 1998
2. David S, Kümpers P, Seidler V, Biertz F, Haller H, Fliser D: Diagnostic value of N-terminal pro-B-type natriuretic peptide (NT-proBNP) for left ventricular dysfunction in patients with chronic kidney disease stage 5 on haemodialysis Nephrol Dial Transplant 23: 1370-1377, 2008
3. Metry G, Hall C, Wilkstrom B, Kallskog V, Hansell P, Danielson B: Fluid balance in patients with chronic renal failure assessed with N-terminal proatrial natriuretic peptide, atrial natriuretic peptide and ultrasonography. Acta Physiol 171: 117-122, 2001 (Pubitemid 33757145)
4. Fagugli RM, Pasini P, Quintaliani G, Pasticici F, Cia G, Cicconi B, Ricciardi D, Santirosi PV, Buoncristiani E, Timio F, Valente F, Buoncristiani U: Association between brain natriuretic peptide and extracellular water in haemodialysis patients. Nephron Clin Pract 95: c60-c66, 2003
5. Sheen V, Bhalla V, Tulua-Tata A, Bhalla MA, Weiss D, Chiu A, Abdeen O, Mullaney S, Maisel A. The use of B-type natriuretic peptide to assess volume status in patients with end-stage renal disease. Am Heart J 153: 244. e1-e5, 2007
6. Sun L, Sun Y, Zhao X, Xu C, Chen D, Li L, Ma Y, Rong S, Mei C: Predictive role of BNP and N-proBNP in haemodialysis patients. Nephron Clin Pract 110: c178-c184, 2008
7. Paniagua R, Ventura MD, Avila-Diaz M, Hinojosa-Heredia H, Mendez-Duran A, Cueto-Manzano A, Cisneros A, Ramos A, Mandonia-Juseino C, Belio-Caro F, Garcia-Contreras F, Trinidad-Ramos P, Vazquez R, Ilabaca B, Alcantara G, Amato D: NT-proBNP, fluid volume overload and dialysis modality are independent predictors of mortality in ESRD patients. Nephrol Dial Transplant 25: 551-557, 2010
8. Davenport A, Willicombe MK: V Comparison of fluid status in patients treated by different modalities of peritoneal dialysis using multi-frequency bio-impedance. Int J Artif Organs 32: 779-786, 2009
9. Moran N, Buscombe J, Davenport A: Predicting cardiac events using adenosine triphosphate myocardial perfusion scintography in renal transplant candidates. J Nephrol Renal Transplant 1: 41-52, 2008
10. Goto T, Takase H, Toriyama T, Sugimura T, Kurita Y, Masuda H, Hayashi K, Ueda R, Dohi Y: Increased circulating levels of natriuretic peptides predict future cardiac events in patients with chronic haemodialysis. Nephron 92: 610-615, 2002
11. Naganuma T, Sugimura K, Wada S, Yasumoto R, Sugimura T, Masuda C, Uchida J, Nakatani T: The prognostic role of brain natriuretic peptides in haemodialysis patients. Am J Nephrol 22: 437-444, 2002
12. Jacobs LH, van der Kerkhof JJ, Mingels AM, Passos VL, Kleijnen VW, Mazairac AH, van der Sande FM, Wodzig WK, Konings VW, Leunissen KM, van Dieijen-Visser MP, Kooman JP: Inflammation overhydration and cardiac biomarkers in haemodialysis patients: A longitudinal study. Nephrol Dial Transplant 25: 243-248, 2010
13. Choi SY, Lee JE, Jang EH, Kim MO, Baek H, Ki CS, Park SW, Kim DJ, Huh WS, O HY, Kim YG: Association between changes in N-terminal pro-brain natriuretic peptide levels and changes in left ventricular mass index in stable haemodialysis patients. Nephron Clin Pract 110: c93-c100, 2008
14. Goldfarb-Rumyantzev AS, Chelamcharla M, Bray BE, Leypoldt JK, Lavasani I, Nelson N, Lavasani T, Baird B, Cheung AK: Volume indicators and left ventricular mass during aggressive volume management in patients on thrice weekly haemodialysis. Nephron Clin Pract 113: c270-c280, 2009
15. Leunissen KML, van den Berg BW, van Hoof JP: Ionized calcium plays a pivotal role in controlling blood pressure during haemodialysis. Blood Purif 7: 233-239, 1989
16. Gabutti L, Bianchi G, Soldini D, Marone C, Burnier M: Haemodynamic consequences of changing bicarbonate and calcium concentrations in haemodialysis fluids. Nephrol Dial Transplant 24: 973-981, 2009
17. Davenport A, Willicombe MK: Hydration status does not influence peritoneal equilibration test ultrafiltration volumes. Clin J Am Soc Nephrol 4: 1207-1212, 2009
18. Gangji AS, Brimble KS, Margetts PJ. Association between markers of inflammation, fibrosis and hypervolaemia in peritoneal dialysis patients. Blood Purif 28; 354-358, 2009
19. Lee JA, Kim DH, Yoo SJ, Oh DJ, Yu SH, Kong ET: Association between serum N terminal natriuretic peptide concentration and left ventricular dysfunction and extracellular water in continuous ambulatory peritoneal dialysis patients. Perit Dial Int 26: 360-365, 2006
20. Madsen LH, Ladefoged S, Corell P, Schou M, Hildebrandt PR, Atar D. N-terminal pro-brain natriuretic peptide predicts mortality in patients with end-stage renal disease in haemodialysis. Kidney Int 71: 548-554, 2007
21. van den Kerkhof JJ, Van der Sande FM, Leunissen K, Kooman JP: Are natriuretic peptides useful biomarkers in dialysis patients? Perit Dial Int 27: 636-640, 2007